Sharon C. Murray

2.0k total citations
44 papers, 1.4k citations indexed

About

Sharon C. Murray is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Sharon C. Murray has authored 44 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Pathology and Forensic Medicine and 6 papers in Surgery. Recurrent topics in Sharon C. Murray's work include Colorectal Cancer Screening and Detection (6 papers), Genetic factors in colorectal cancer (5 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers). Sharon C. Murray is often cited by papers focused on Colorectal Cancer Screening and Detection (6 papers), Genetic factors in colorectal cancer (5 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers). Sharon C. Murray collaborates with scholars based in United States, United Kingdom and Italy. Sharon C. Murray's co-authors include D. Bafaloukos, C. Papadimitriou, Helena Linardou, Evangelos Briasoulis, Robert S. Sandier, John T. Woosley, Robert S. Sandler, Lawrence L. Kupper, Marilyn Tseng and Joseph A. Galanko and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Sharon C. Murray

41 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon C. Murray United States 17 389 385 200 165 161 44 1.4k
Joseph A. Odin United States 29 522 1.3× 255 0.7× 389 1.9× 144 0.9× 58 0.4× 69 2.4k
Dirk Eulberg Germany 30 1.5k 3.8× 497 1.3× 300 1.5× 127 0.8× 114 0.7× 49 3.6k
Takashi Himoto Japan 25 557 1.4× 287 0.7× 299 1.5× 194 1.2× 53 0.3× 137 2.1k
Yoshihide Fujigaki Japan 28 1.0k 2.6× 206 0.5× 348 1.7× 411 2.5× 111 0.7× 166 2.9k
Harumasa Ohyanagi Japan 20 404 1.0× 387 1.0× 498 2.5× 230 1.4× 255 1.6× 149 1.7k
Wei‐Ting Liao Taiwan 25 790 2.0× 444 1.2× 164 0.8× 274 1.7× 89 0.6× 127 2.3k
Akira Hiramatsu Japan 25 266 0.7× 307 0.8× 458 2.3× 214 1.3× 76 0.5× 147 2.5k
Youming Peng China 27 917 2.4× 144 0.4× 353 1.8× 303 1.8× 68 0.4× 133 2.8k
Jianping Zhang China 26 712 1.8× 426 1.1× 231 1.2× 299 1.8× 54 0.3× 91 1.7k
Liu Yang China 23 718 1.8× 239 0.6× 142 0.7× 191 1.2× 60 0.4× 149 1.9k

Countries citing papers authored by Sharon C. Murray

Since Specialization
Citations

This map shows the geographic impact of Sharon C. Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon C. Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon C. Murray more than expected).

Fields of papers citing papers by Sharon C. Murray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon C. Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon C. Murray. The network helps show where Sharon C. Murray may publish in the future.

Co-authorship network of co-authors of Sharon C. Murray

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon C. Murray. A scholar is included among the top collaborators of Sharon C. Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon C. Murray. Sharon C. Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wedner, H. James, Emel Aygören‐Pürsün, Jonathan A. Bernstein, et al.. (2021). Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2). The Journal of Allergy and Clinical Immunology In Practice. 9(6). 2305–2314.e4. 35 indexed citations
2.
Anderson, John, Rémi Gagnon, Jessica Best, et al.. (2021). Reduction in Attacks in Hereditary Angioedema (HAE) With Berotralstat is Consistent Regardless of Prior Prophylactic Treatment: A Subgroup Analysis of the Phase 3 APeX-2 Trial. Journal of Allergy and Clinical Immunology. 147(2). AB23–AB23. 1 indexed citations
3.
4.
Simpkins, Fiona, Aurea E. Flores, Christina Chu, et al.. (2013). Chemoimmunotherapy Using Pegylated Liposomal Doxorubicin and Interleukin-18 in Recurrent Ovarian Cancer: A Phase I Dose-Escalation Study. Cancer Immunology Research. 1(3). 168–178. 41 indexed citations
5.
Robertson, Michael J., Justin Kline, Herbert Struemper, et al.. (2013). A Dose-Escalation Study of Recombinant Human Interleukin-18 in Combination With Rituximab in Patients With Non-Hodgkin Lymphoma. Journal of Immunotherapy. 36(6). 331–341. 29 indexed citations
6.
Murray, Sharon C., Evangelos Briasoulis, Helena Linardou, D. Bafaloukos, & C. Papadimitriou. (2012). Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategies. Cancer Treatment Reviews. 38(7). 890–903. 214 indexed citations
7.
Olmos, David, Douglas S. Barker, Rohini Sharma, et al.. (2011). Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies. Clinical Cancer Research. 17(10). 3420–3430. 134 indexed citations
8.
Adams, Laurel M., Brendan M. Johnson, John W. Bauman, et al.. (2010). Lack of effect of casopitant on the pharmacokinetics of docetaxel in patients with cancer. Cancer Chemotherapy and Pharmacology. 67(4). 783–790. 5 indexed citations
9.
Bauman, John W., Joyce Antal, Laurel M. Adams, et al.. (2010). Effect of hepatic or renal impairment on the pharmacokinetics of casopitant, a NK-1 receptor antagonist. Investigational New Drugs. 30(2). 662–671. 6 indexed citations
10.
Hussey, Elizabeth K., Robert L. Dobbins, R Stoltz, et al.. (2010). Multiple‐Dose Pharmacokinetics and Pharmacodynamics of Sergliflozin Etabonate, a Novel Inhibitor of Glucose Reabsorption, in Healthy Overweight and Obese Subjects: A Randomized Double‐Blind Study. The Journal of Clinical Pharmacology. 50(6). 636–646. 40 indexed citations
11.
Murray, Sharon C., et al.. (2008). A multivariate approach to sample size calculations for thorough QT studies. NCSU Libraries Repository (North Carolina State University Libraries). 2 indexed citations
12.
Ford, Susan L., Y. Sunila Reddy, Sharon C. Murray, et al.. (2006). Single-Dose Safety and Pharmacokinetics of Brecanavir, a Novel Human Immunodeficiency Virus Protease Inhibitor. Antimicrobial Agents and Chemotherapy. 50(6). 2201–2206. 17 indexed citations
13.
Kirke, Peadar N., James L. Mills, Anne M. Molloy, et al.. (2004). Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case-control study. BMJ. 328(7455). 1535–1536. 99 indexed citations
14.
Marple, Virgil A., et al.. (2003). Next Generation Pharmaceutical Impactor (A New Impactor for Pharmaceutical Inhaler Testing). Part II: Archival Calibration. Journal of Aerosol Medicine. 16(3). 301–324. 109 indexed citations
15.
Shaheen, Nicholas J., Melissa A. Crosby, Michael O’Malley, et al.. (2000). The practices and attitudes of primary care nurse practitioners and physician assistants with respect to colorectal cancer screening. The American Journal of Gastroenterology. 95(11). 3259–3265. 14 indexed citations
16.
Sandler, Robert S., Joseph A. Galanko, Sharon C. Murray, James F. Helm, & John T. Woosley. (1998). Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas. Gastroenterology. 114(3). 441–447. 108 indexed citations
17.
Russo, Mark W., Sharon C. Murray, John I. Wurzelmann, John T. Woosley, & Robert S. Sandier. (1997). Plasma selenium levels and the risk of colorectal adenomas. Nutrition and Cancer. 28(2). 125–129. 71 indexed citations
18.
Tseng, Marilyn, Sharon C. Murray, Lawrence L. Kupper, & Robert S. Sandier. (1996). Micronutrients and the Risk of Colorectal Adenomas. American Journal of Epidemiology. 144(11). 1005–1014. 109 indexed citations
19.
Murray, Sharon C., et al.. (1996). Regulation of granulosa cell-derived ovarian metalloproteinase inhibitor(s) by prolactin. Reproduction. 107(1). 103–108. 11 indexed citations
20.
Murray, Sharon C. & Ronald W. Helms. (1990). Linear models with generalized ar(1) covariance structure for irregularly-timed data. NCSU Libraries Repository (North Carolina State University Libraries). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph A. Odin Breakdown of academic impact, for papers by Dirk Eulberg Breakdown of academic impact, for papers by Takashi Himoto Breakdown of academic impact, for papers by Yoshihide Fujigaki Breakdown of academic impact, for papers by Harumasa Ohyanagi Breakdown of academic impact, for papers by Wei‐Ting Liao Breakdown of academic impact, for papers by Akira Hiramatsu Breakdown of academic impact, for papers by Youming Peng Breakdown of academic impact, for papers by Jianping Zhang Breakdown of academic impact, for papers by Liu Yang
Rankless by CCL
2026